NCCTG N0821 (Alliance): A phase II first-line study of pemetrexed, carboplatin and bevacizumab in elderly patients with advanced nonsquamous non-small cell lung cancer with good performance status

PURPOSE: We hypothesized that the combination of bevacizumab, carboplatin and pemetrexed will be an effective first-line regimen in fit, elderly patients with nonsquamous NSCLC. PATIENTS AND METHODS: Treatment-naïve, stage IIIB/IV nonsquamous NSCLC patients ≥ 70 years old with good performance statu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Dy, Grace K., Molina, Julian R., Qi, Yingwei, Ansari, Rafat, Thomas, Sachdev, Ross, Helen J., Soori, Gamini, Anderson, Daniel, Aubry, Marie Christine, Meyers, Jeffrey, Adjei, Araba A., Mandrekar, Sumithra, Adjei, Alex A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4145612/
https://ncbi.nlm.nih.gov/pubmed/25157767
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JTO.0000000000000217
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados